Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Saprochaete suaveolens genome sequencing

PROVIDER: PRJEB28673 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR3039972_1.fastq.gz	Fastqsanger.gz
	ERR3039972_2.fastq.gz	Fastqsanger.gz
	ERR3039974_1.fastq.gz	Fastqsanger.gz
	ERR3039974_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Project description:Saprochaete fungicola genome sequencing

| PRJEB30635 | ENA

Project description:Nicotiana suaveolens genome sequencing

| PRJNA1008052 | ENA

Project description:Saprochaete ingens CBS 517.90 genome sequencing

| PRJEB33997 | ENA

Trametes suaveolens strain:KMRB14101203

Project description:Trametes suaveolens strain:KMRB14101203 Genome sequencing

| PRJNA1306005 | ENA

Populus suaveolens

Project description:Populus suaveolens Genome sequencing and assembly

| PRJNA833840 | ENA

Project description:Whole genome sequencing of Saprochaete clavata isolates

| PRJEB36345 | ENA

3alpha-acetonyltabersonine induces glioblastoma apoptosis via the inhibition of DNA damage repair

Project description:we report the antitumor activity of an indole alkaloid, 3alpha-acetonyltabersonine, which was isolated from Melodinus suaveolens. 3alpha-acetonyltabersonine was found to be cytotoxic to glioblastoma cell line and stem cells at low concentrations.

2017-02-28 | GSE95392 | GEO

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Magnusiomyces paraingens

Project description:Saprochaete ingens overview

| PRJNA772846 | ENA

Erythrophleum suaveolens

Project description:Erythrophleum suaveolens overview

| PRJNA1051744 | ENA